Download Docs
Export

FALK PHARMA

79447717 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Dec. 19, 2025
Serial No. 79447717
Examining Attorney JENNIFER LYNN O'BRIEN
Class Medicinal preparations and substances; pharmaceuticals and natural remedies; pharmaceutical drugs; pharmaceutical preparations; pharmaceuticals; diagnostic preparations and materials, for medical and veterinary purposes; diagnostic agents for pharmaceutical use; companion diagnostics, i.e. reagents that support the prediction of the effect of a drug, the presence or absence of side effects and the selection of drugs to be administered to the respective patient; in-vitro diagnostics, in particular reagents, solutions and test strips for the analysis of biological samples for clinical and medical-diagnostic purposes; reagents, solutions and test strips for clinical and medical purposes; medical, diagnostic reagents for the analysis of body fluids, in particular saliva and blood; test strips for the detection of substances in body fluids, in particular saliva and blood, for medical laboratory purposes and for medical use; compounds, namely active ingredients and/or reagents, materials and preparations for clinical diagnostics or therapy-related diagnostics; chemical products for use in medical diagnostics, in particular products for personalized medicine and/or gene analysis and/or genome sequencing; chemical products for use in RNA, DNA and antibody analyses for medical purposes, in particular in the field of personalized medicine; pharmaceutical products filled in pre-filled syringes; cachets for pharmaceutical purposes; pharmaceutical agents affecting digestive organs; pharmaceutical agents affecting metabolism; pharmaceutical preparations and products for the prevention and treatment of inflammatory and bacterial diseases; pharmaceutical preparations and products for the prevention of bacterial complaints; pharmaceutical preparations and products for the prevention and treatment of immune system disorders and autoimmune disorders; pharmaceutical preparations and products for immune system adjustment; pharmaceutical preparations and products for regulating the immune system; pharmaceutical preparations and products for the prevention and treatment of digestive diseases and digestive disorders; pharmaceutical preparations and products for the prevention and treatment of high blood pressure; pharmaceutical preparations and products for activating cell function; pharmaceutical preparations and products for the peripheral nervous system; pharmaceutical preparations and products for the prevention and treatment of kidney diseases and kidney complaints; pharmaceutical preparations and products for the prevention and treatment of liver diseases; pharmaceutical preparations and products for the prevention and treatment of metabolic disorders and metabolic diseases; pharmaceutical preparations and products for the prevention and treatment of skin diseases and skin problems; pharmaceutical preparations and products for the prevention and treatment of bone diseases; pharmaceutical preparations and products for the prevention and treatment of rheumatic diseases; pharmaceutical preparations and products for the prevention and treatment of depression; pharmaceutical preparations and products for the prevention and treatment of musculoskeletal disorders; pharmaceutical products and preparations for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations and products for use in organ transplantation; pharmaceutical preparations and products for use in dermatology; pharmaceutical preparations and products for use in urology; pharmaceutical preparations and products for the treatment of hypercholesterolemia; pharmaceutical preparations and products for the treatment of hyperlipidemia; pharmaceutical preparations and products for the prevention of osteoporosis; pharmaceutical preparations and products for the treatment of the digestive tract including the esophagus; pharmaceutical preparations and products in the form of capsules, powders, tablets, sachets, juices, suspensions, granules, enema preparations, suppositories and suppositories [for rectal use], rectal foam for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, in particular herbal preparations, and products for the treatment of intestinal constipation, celiac disease, hemorrhoidal disorders, pancreatitis [in particular acute pancreatitis], elevated cholesterol levels, zinc deficiencies, irritable bowel syndrome or for supportive therapy for diarrhea; pharmaceutical preparations and products for bowel cleansing before a colonoscopy; immunosuppressants and cortisone preparations for the treatment of organ transplants, inflammatory bowel diseases, skin diseases and rheumatic joint inflammation; pharmaceutical preparations and products to support the body in connection with organ transplantation; pharmaceutical preparations and products for the treatment of rheumatoid arthritis, chronic inflammatory bowel diseases, in particular crohn's disease or ulcerative colitis, systemic lupus erythematosus, dermatomyositis, polymyositis, chronic active autoimmune hepatitis, polyarteritis nodosa, autoimmune hemolytic anemia, chronic refractory idiopathic thrombocytopenic purpura; pharmaceutical preparations and products for the treatment of chronic intestinal inflammation, in particular microscopic colitis, chronic inflammation of the liver [autoimmune hepatitis] and inflammatory diseases of the esophagus [eosinophilic esophagitis]; pharmaceutical preparations and products for the dissolution of gallstones, for the treatment of chronic diseases of the biliary tract and for the treatment of liver diseases, in particular liver cirrhosis or liver disease associated with cystic fibrosis [cystic fibrosis]; prefilled syringes for medical purposes.; 005; 006; 018; 044; 046; 051; 052; 026; 039; 044; 002; 005; 022; 023; 029; 037; 038; 050; 100; 101; 102; 100; 101; 107; 100; 101; 100; 101
FALK PHARMA
Case Type Trademark Service mark
Status A non-final Office action has been sent (issued) to the applicant. This is a letter from the examining attorney requiring additional information and/or making an initial refusal. The applicant must respond to this Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Last Updated: 1 day, 9 hours ago
Filing Date # Docket Text
to view the full docket.